College of Life Sciences, Sichuan Normal University , Chengdu, P.R. China.
College of Life Sciences, Sichuan University , Chengdu, P.R. China.
Gut Microbes. 2020 Nov 9;12(1):1-18. doi: 10.1080/19490976.2020.1842990.
Phlorizin (PHZ) is one of phytonutrients in apples that contributes to the health-promoting effect implicated by the saying, 'an apple a day keeps the doctor away'. PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability makes it hard to fully explain its pharmacological mechanisms. This study aimed to investigate the ameliorating effect of PHZ on high-fat diet (HFD)-induced obesity via modulating the "gut microbiota-barrier axis". Firstly, C57BL/6 J mice were fed a normal chow diet (NCD) or HFD coadministered with or without PHZ for 12 weeks. Our results showed that PHZ supplementation significantly reduced HFD-induced body weight gain (.001), alleviated metabolic disorders (MDs) like insulin resistance (.001) and elevation of serum lipopolysaccharides (LPS) (.001), attenuated HFD-induced gut microbiota alterations, enhanced short-chain fatty acids (SCFAs) production (.001), and inhibited fecal LPS production (.001). To investigate the role of the fecal microbiota in the observed beneficial effects, a fecal microbiota transplantation (FMT) experiment was performed by transplanting the feces of the four groups of mice (as donor mice) daily collected from the fourth week to a new batch of acclimatized HFD-fed mice. Our results confirmed that feeding the gut contents of the PHZ-modulated mice could attenuate HFD-induced MDs, accompanied by enhanced glucagon-like peptide 2 (GLP-2) secretion (.001) and restoration of HFD-induced damage in the gut epithelial barrier. This study has provided evidence that the "gut microbiota-barrier axis" was an alternative target for the anti-obesity effect of PHZ. This work has also provided an explanation for the high efficacy of PHZ despite the low bioavailability, and PHZ holds great potential to be developed as a functional food ingredient.
根皮苷(PHZ)是苹果中的一种植物营养素,它有助于解释“一天一苹果,医生远离我”这句话所暗示的促进健康的作用。PHZ 最初被鉴定为钠-葡萄糖共转运蛋白 2(SGLT2)的竞争性抑制剂;然而,其生物利用度低使得很难完全解释其药理机制。本研究旨在通过调节“肠道微生物群-屏障轴”来研究 PHZ 对高脂肪饮食(HFD)诱导肥胖的改善作用。首先,将 C57BL/6J 小鼠喂食正常对照饮食(NCD)或 HFD,并同时给予或不给予 PHZ 共 12 周。我们的结果表明,PHZ 补充显著降低了 HFD 诱导的体重增加(.001),缓解了胰岛素抵抗等代谢紊乱(.001)和血清脂多糖(LPS)的升高(.001),减弱了 HFD 诱导的肠道微生物群改变,增强了短链脂肪酸(SCFAs)的产生(.001),并抑制了粪便 LPS 的产生(.001)。为了研究粪便微生物群在观察到的有益效果中的作用,通过每天从第四周开始将来自四组小鼠(作为供体小鼠)的粪便移植到一批新的适应 HFD 喂养的小鼠中进行粪便微生物群移植(FMT)实验。我们的结果证实,喂养 PHZ 调节的小鼠的肠道内容物可以减轻 HFD 诱导的 MDs,伴随着胰高血糖素样肽 2(GLP-2)分泌的增强(.001)和恢复 HFD 诱导的肠道上皮屏障损伤。本研究为 PHZ 的“肠道微生物群-屏障轴”是其抗肥胖作用的替代靶点提供了证据。这项工作还解释了 PHZ 尽管生物利用度低但具有高功效的原因,并且 PHZ 具有很大的潜力被开发为功能性食品成分。